COMPARATIVE ANALYSIS OF BIOLOGICAL EFFECTS OF SELECTIVE ACTIVATOR OF THE GLUCOCORTICOID RECEPTOR CPDA ON DIFFERENT SUBTYPES OF BREAST CANCER CELL LINES

Glucocorticoids (GCs) are often used as an adjuvant therapy to reduce the adverse effects of chemotherapy in breast cancer patients. Moreover, GCs can display pro-proliferative or anti-proliferative effects on BC cells depending on their molecular subtype. In addition, long-term use of GCs can induc...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	E. M. Zhidkova, K. A. Kuzin, L. R. Tilova, A. V. Savinkova, O. I. Borisova, M. D. Lavrova, V. P. Maximova, K. I. Kirsanov, M. G. Yakubovskaya, E. A. Lesovaya
Formatua:	Artigo
Hizkuntza:	Russo
Argitaratua:	Russian Academy of Sciences, Tomsk National Research Medical Center 2017-12-01
Saila:	Сибирский онкологический журнал
Gaiak:	molecular subtypes of breast cancer glucocorticoids selective activators of glucocorticoid receptor compound a cpda
Sarrera elektronikoa:	https://www.siboncoj.ru/jour/article/view/640
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!